Identification of Monoclonal Antibodies that Distinguish Between 17D-204 and other Strains of Yellow Fever Virus

References

1. Barrett A. D. T. 1987; Yellow fever vaccines. Bulletin de l’lnstitut Pasteur 85:103–124
   [Google Scholar]
2. Barrett A. D. T., Gould E. A. 1986; Comparison of neurovirulence of different strains of yellow fever virus for mice. Journal of General Virology 67:631–637
   [Google Scholar]
3. Barrett A. D. T., Pryde A., Medlen A. R., Ledger T. N., Whitby J. E., Gibson C. A., DeSilva M., Groves D. J., Langley D. J., Minor P. D. 1989; Examination of the envelope glycoprotein of yellow fever vaccine viruses with monoclonal antibodies. Vaccine 7:333–336
   [Google Scholar]
4. Boere W. A. M., Harmsen M., Kraaijeveld C. A., Snippe H. 1986; Antigenic differences between virulent and avirulent strains of Semliki Forest viruses detected with monoclonal antibodies. Archives of Virology 88:105–112
   [Google Scholar]
5. Buckley A., Gould E. A. 1985; Neutralization of yellow fever virus studied using monoclonal and polyclonal antibodies. Journal of General Virology 66:2523–2531
   [Google Scholar]
6. Cammack N., Gould E. A. 1986; Topographical analysis of epitope relationships on the envelope glycoprotein of yellow fever 17D vaccine and the wild-type Asibi parent virus. Virology 150:333–341
   [Google Scholar]
7. DeCock K. M., Monath T. P., Nasidi A., Tukei P. M., Enriquez J., Lichfield P., Craven R. B., Fabiyi A., Okafor B. C., Ravaonjanahary C., Sorungbe A. 1988; Epidemic yellow fever in Eastern Nigeria, 1986. Lancet i:630–633
   [Google Scholar]
8. Deubel V., Camicas J. L., Pandare D., Robert V., Digoutte J. P., Germain M. 1981; Developpement de souches sauvages et vaccinales du virus de la fievre jaune dans les cellules de Aedes aegyptiet transmission au souriceau. Annals of Virology 132E:41–50
   [Google Scholar]
9. Gentry M. K., Henchal E. A., McCown J. M., Brandt W. E., Dalrymple J. M. 1982; Identification of distinct antigenic determinants on dengue 2 virus using monoclonal antibodies. American Journal of Tropical Medicine and Hygiene 31:548–555
   [Google Scholar]
10. Geske T., Nichtila P., Seethaler H., Koch M. A., L’Age-Stehr J. 1983; Establishment of hybridomas producing antibodies to viral surface epitopes related to pathogenic properties of yellow fever virus strains. Immunobiology 165:263
    [Google Scholar]
11. Gould E. A., Buckley A., Cammack N., Barrett A. D. T., Clegg J. C. S., Ishak R., Varma M. G. R. 1985; Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies. Journal of General Virology 66:1369–1382
    [Google Scholar]
12. Gould E. A., Buckley A., Barrett A. D. T., Cammack N. 1986; Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice. Journal of General Virology 67:591–595
    [Google Scholar]
13. Gould E. A., Buckley A., Cane P. A., Higgs S., Cammack N. 1989; Use of a monoclonal antibody specific for wild-type yellow fever virus to identify a wild-type antigenic variant in 17D vaccine pools. Journal of General Virology 70:1889–1894
    [Google Scholar]
14. Grady L. J., Kinch W. 1985; Two monoclonal antibodies against La Crosse virus show host-dependent neutralizing activity. Journal of General Virology 66:2773–2776
    [Google Scholar]
15. Henchal E. A., McCown J. M., Burke D. S., Seguin M. C., Brandt W. E. 1985; Epitopic analysis of antigenic determinants on the surface of dengue 2 virions using monoclonal antibodies. American Journal of Tropical Medicine and Hygiene 34:162–169
    [Google Scholar]
16. James W. S., Millican D. 1986; Host-adaptive antigenic variation in bunyaviruses. Journal of General Virology 67:2803–2806
    [Google Scholar]
17. Mathis E., Sellards A. S., Laigret S. 1928; Sensibilite du Macacos rhesusau virus de la fievre jaune. Compte rendu hebdoma- daire des seances de L'Academie des sciences 186:604–606
    [Google Scholar]
18. Mendez M. R., Calishier C. H., Kruger H., Sipan F., Sanchez S., Lazuick J. S. 1984; A continuing focus of yellow fever in the Apurimac River valley, Ayacucho, Peru, and the first isolation of yellow fever virus in that country. Bulletin of the Pan American Health Organization 18:172–179
    [Google Scholar]
19. Monath T. P., Kinney R. M., Schlesinger J. J., Brandriss M. W., Brés P. 1983; Ontogeny of yellow fever 17D vaccine: RNA oligonucleotide fingerprint and monoclonal antibody analyses of vaccine produced world-wide. Journal of General Virology 64:627–637
    [Google Scholar]
20. Monath T. P., Wands J. R., Hill L. J., Brown N. V., Marciniak R. A., Wong M. A., Gentry M. K., Burke D. S., Grant J. A., Trent D. W. 1986; Geographic classification of dengue 2 virus strains by antigen signature analysis. Virology 154:313–324
    [Google Scholar]
21. Roehrig J. T., Mathews J. H., Trent D. W. 1983; Identification of epitopes on the E glycoprotein of Saint Louis encephalitis virus using monoclonal antibodies. Virology 128:118–126
    [Google Scholar]
22. Schlesinger J. J., Brandriss M. W., Monath T. P. 1983; Monoclonal antibodies distinguish between wild-type and vaccine strains of yellow fever virus by neutralization, hemagglutination inhibition and immune precipitation of the virus envelope protein. Virology 125:8–17
    [Google Scholar]
23. Stollar V., Stollar B. D., Koo R., Harrap K. A., Schlesinger R. W. 1976; Sialic acid contents of Sindbis virus from vertebrate and mosquito cells. Equivalence of biological and immunological properties. Virology 69:104–115
    [Google Scholar]
24. Theiler M., Smith H. H. 1937; Effect of prolonged cultivation in vitroupon pathogenicity of yellow fever virus. Journal of Experimental Medicine 65:767–786
    [Google Scholar]
25. Westaway E. G., Brinton M. A., Gaidamovich S. Y., Horzinek M. C., Igarashi A., Kääriäinen L., Lvov D. K., Porterfield J. S., Trent D. W. 1985; Flaviviridae. Intervirology 24:183–192
    [Google Scholar]